2026 Interim Report
Filed with HKEX · Stock code 314 · · 78 pages · English and Chinese
Corporate Information Financial Summary Management Discussion and Analysis Other Information Independent Auditor’s Review Report Interim Condensed Consolidated Statement of Profit or Loss and Other Comprehensive Income 公司資料 2 財務摘要 6 管理層討論及分析 8 其他資料 28 獨立核數師審閱報告 40 中期簡明合併損益及其他全面收益表 42 Interim Condensed Consolidated Statement of Financial Position 中期簡明合併財務狀況表 44 Interim Condensed Consolidated Statem
Sipai Health Technology Co., Ltd. on 6ix
Earlier from Sipai Health Technology
- Sipai Health Technology's Unit Disposes 100% Stake In Sipai Zhihe Technology (Guangzhou) Co
- Sipai Health Technology Says Bixun Pharmaceutical To Buy Shanze Technology
- Sipai Health Technology Expects Normalized Net Loss Of No More Than RMB50 MLN For FY
Later from Sipai Health Technology
- Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026
- Major transaction disposal of 100% equity interest in the target company
Follow Sipai Health Technology into a list and get an email when it puts out news.
Follow Sipai Health Technology